Aberrant overexpression of pro-survival Bcl-2 family proteins or reduced expression of pro-apoptotic Bcl-2 family proteins, both of which suppress apoptosis, are frequently observed in various types of cancer. This evidence concerns the gene BCL2 and cancer.